Clinical Trial Update: aHUS Observational Long Term Follow-Up

View source ↗

Summary

An observational long-term follow-up trial for atypical hemolytic uremic syndrome has been terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Atypical Hemolytic Uremic Syndrome

Snippet

Sponsor: Alexion Pharmaceuticals, Inc. | Conditions: Atypical Hemolytic Uremic Syndrome | Status: TERMINATED